NEW YORK (360Dx) – A point-of-care test that monitors the immune system's response without requiring manual processing could help clinicians treating sepsis, a condition that should be quickly detected to provide an optimal clinical effect, according to the test's developers at the University of Illinois and the Carle Foundation Hospital in Urbana, Illinois.

To monitor the immune system's response during infection or inflammation, the test looks for an increase in the expression of the CD64 protein marker on specific types of white blood cells called neutrophils.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.


In this webinar, Jill Viles, an Iowa mother with no clinical training, shares her story of how she self-diagnosed her rare condition, a muscle-wasting disease caused by a mutation in the LMNA gene. She will also discuss how she discovered that a mutation in the same gene is the underlying cause for the excess muscle phenotype exhibited by Canadian Olympic hurdler Priscilla Lopes-Schliep.